SomaLogic down on weak revenue forecast
29/03/2023 11:15
** Shares of diagnostic company SomaLogic Inc SLGC.O down
13.6% at $2.02 in premarket trading
** SLGC said on Tuesday it expects 2023 revenue between $80
mln and $84 mln, compared to ests of $92.8 mln, according to
Refinitiv data
** Co added its CEO Roy Smythe has stepped down from his
role
** Q4 revenue fell 18.1% to $18.8 mln, but was above
Street's ests of $16.6 mln
** As of last close, stock fell ~7% this year
(Reporting by Tiyashi Datta in Bengaluru)
((tiyashi.datta@thomsonreuters.com))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders